Business ❯ Industry

Pharmaceutical Industry

Investment Manufacturing Production Growth Drug Development Supply Chain Public-Private Partnerships Pharmacy Operations Market Competition Innovation Drug Manufacturing

Merck to Buy Bio‑Techne for $11.3 Billion

Merck says the purchase will expand its lab‑tools business into cell and gene therapy, strengthen precision‑diagnostic offerings, deliver about €140 million in annual cost synergies, lift operating margins, require regulatory and shareholder approvals.

Hesse Transfers DFB Tax Responsibility From Frankfurt to Bad Homburg

EU Strikes Provisional Deal to Boost Home Production of Critical Medicines

United Therapeutics Teams With Varda to Test Space-Made Drug Formulations

SICC Pledges C$2 Billion Drug Ingredients Plant in Hidalgo Under MoU

White House Projects $529 Billion in Savings From Trump’s MFN Drug Pricing Plan

ANMAT Suspends Global Pharma Group Over Cold-Chain and Traceability Failures

India Prioritizes Petrochemical Feedstocks for Pharma as Methanol Transport Lags

Trump Imposes New Drug Tariffs, Extends Metal Duties to Finished Goods

Industry Warns Iran Conflict Threatens Global Helium Supply

Mexico Launches IMPI–COFEPRIS Portal for Real-Time Health Patent Data

Mexican Court Revives Denosumab Patent, Extends Amgen Exclusivity to 2027

Brazil Government Opposes Patent Breaks for Weight-Loss Pens After House Fast-Tracks Bill

Germany’s Pharmacy Count Falls to 16,601, Lowest in Nearly 50 Years

EU Seals Provisional Overhaul of Drug Rules to Speed Access and Spur Innovation

German Chemical Industry Sounds Alarm, Sees Stagnation in 2026

Germany Launches Pharma and MedTech Strategy Talks to Tackle Drug Shortages

Mexico Prepares Sanctions for Drug Suppliers After Missed Deadline as Supply Rebounds

Fabtech Technologies' Rs 230 Crore IPO Closes Fully Subscribed; Listing Planned for Oct 7

VFA Study Puts Germany’s 2024 Bureaucracy Cost at €67 Billion